Standard dose of Ustekinumab for childhood-onset deficiency of interleukin-36 receptor antagonist

Ann Rheum Dis. 2018 Dec;77(12):e88. doi: 10.1136/annrheumdis-2017-212793. Epub 2017 Dec 19.

Authors

Bilade Cherqaoui Jr^{1

2}, Linda Rossi-Semerano^{1

2}, Maryam Piram^{1

2}, Isabelle Koné-Paut^{1

2}

Affiliations

¹ Paediatric Rheumatology, APHP, CHU Bicêtre, University of Paris Sud, Le Kremlin-Bicetre, Ile-de-France, France.
² CEREMAIA, French Reference Centre for Auto-Inflammatory Diseases and Inflammatory Amyloidosis, Le Kremlin-Bicêtre, Ile-de-France, France.

PMID: 29259046
DOI: 10.1136/annrheumdis-2017-212793

No abstract available

Publication types

Letter
Comment

MeSH terms

Interleukin-12
Interleukin-23*
Ustekinumab*

Substances

Interleukin-23
Interleukin-12
Ustekinumab